Focal ultrasound may offer intermediate-risk prostate cancer alternative to radiation, surgery - Medicine Matters oncology

Magnetic resonance imaging-guided focal ultrasound therapy is a feasible treatment for grade group 2–3 prostate cancer, indicate phase 2b trial findings published in The Lancet Oncology.

medwireNews: Magnetic resonance imaging (MRI)-guided focal ultrasound therapy is a feasible treatment for grade group 23 prostate cancer, indicate phase 2b trial findings published in The Lancet Onco… [+3767 chars]

full article...